Abstract

BackgroundThe phase 3 IMpower150 trial showed significantly improved progression-free survival (PFS) and overall survival (OS) with atezolizumab plus bevacizumab plus carboplatin-paclitaxel (ABCP) versus bevacizumab plus carboplatin-paclitaxel (BCP) in chemotherapy-naive patients...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Brief Report: First-line Pembrolizumab in Metastatic Non-Small Cell Lung Cancer Habouring MET Exon 14 Skipping Mutation and PD-L1 ≥50% (GFPC 01-20 Study)
Florian Guisier ... Chantal Decroisette
Clinical Lung Cancer | VOL. 23
Florian Guisier, et. al.Florian Guisier ... Chantal Decroisette
17 Sep 2022
Randomized, open-label, multicenter phase II study of bevacizumab in combination with carboplatin and paclitaxel in chemotherapy-naive Japanese patients with advanced or recurrent nonsquamous non-small cell lung cancer (NSCLC): JO19907
Y Ichinose ... N Saijo
Journal of Clinical Oncology | VOL. 27
Y Ichinose, et. al.Y Ichinose ... N Saijo
20 May 2009
Nab-paclitaxel in combination with Bevacizumab in patients with non-squamous non-small cell lung cancer after failure of at least one prior systemic regimen.
Yuxin Mu ... Yixiang Zhu
Journal of Cancer | VOL. 11
Yuxin Mu, et. al.Yuxin Mu ... Yixiang Zhu
01 Jan 2020
364 KRAS mutations in patients with nonsquamous non–small-cell lung cancer: prevalence and relationship with PD-L1 expression, tumor mutation burden and smoking status
... Gilberto Lopes
Journal for ImmunoTherapy of Cancer | VOL. 9
, et. al. ... Gilberto Lopes
01 Nov 2021
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma
Sofie Kirial Mørk ... Inge Marie Svane
Journal for ImmunoTherapy of Cancer | VOL. 12
Sofie Kirial Mørk, et. al.Sofie Kirial Mørk ... Inge Marie Svane
23 May 2024
Enhancing IgA-mediated neutrophil cytotoxicity against neuroblastoma by CD47 blockade
Chilam Chan ... Jeanette Leusen
Journal for ImmunoTherapy of Cancer | VOL. 12
Chilam Chan, et. al.Chilam Chan ... Jeanette Leusen
23 May 2024
Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors: is the time ripe?
Lorenzo Gervaso ... Nicola Fazio
Journal for ImmunoTherapy of Cancer | VOL. 12
Lorenzo Gervaso, et. al.Lorenzo Gervaso ... Nicola Fazio
23 May 2024
Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10/STAT3 axis in a colorectal cancer model
Zhenqiang Sun ... Junhong Hu
Journal for ImmunoTherapy of Cancer | VOL. 12
Zhenqiang Sun, et. al.Zhenqiang Sun ... Junhong Hu
23 May 2024
View more papers